Debt-to-equity in % of Relay Therapeutics, Inc. from Q1 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Relay Therapeutics, Inc. quarterly Debt-to-equity history and change rate from Q1 2021 to Q3 2025.
  • Relay Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 11%, a 12.5% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Relay Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 11% -2% -12% 30 Sep 2025
Q2 2025 11% -3% -21% 30 Jun 2025
Q1 2025 12% -3% -23% 31 Mar 2025
Q4 2024 12% -4% -25% 31 Dec 2024
Q3 2024 12% -5% -28% 30 Sep 2024
Q2 2024 14% -3% -20% 30 Jun 2024
Q1 2024 15% -1% -5.9% 31 Mar 2024
Q4 2023 16% +1% +8.8% 31 Dec 2023
Q3 2023 17% +3% +21% 30 Sep 2023
Q2 2023 17% +3% +23% 30 Jun 2023
Q1 2023 16% +2% +14% 31 Mar 2023
Q4 2022 15% +3% +23% 31 Dec 2022
Q3 2022 14% +4% +40% 30 Sep 2022
Q2 2022 14% +6% +88% 30 Jun 2022
Q1 2022 14% +7% +89% 31 Mar 2022
Q4 2021 12% 31 Dec 2021
Q3 2021 10% 30 Sep 2021
Q2 2021 7% 30 Jun 2021
Q1 2021 8% 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.